CRNX
Price
$29.80
Change
+$0.36 (+1.22%)
Updated
Jul 3 closing price
Capitalization
2.79B
32 days until earnings call
ZVRA
Price
$9.74
Change
+$0.33 (+3.51%)
Updated
Jul 3 closing price
Capitalization
532.58M
43 days until earnings call
Interact to see
Advertisement

CRNX vs ZVRA

Header iconCRNX vs ZVRA Comparison
Open Charts CRNX vs ZVRABanner chart's image
Crinetics Pharmaceuticals
Price$29.80
Change+$0.36 (+1.22%)
Volume$461.1K
Capitalization2.79B
Zevra Therapeutics
Price$9.74
Change+$0.33 (+3.51%)
Volume$1.18M
Capitalization532.58M
CRNX vs ZVRA Comparison Chart in %
Loading...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRNX vs. ZVRA commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRNX is a Hold and ZVRA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (CRNX: $29.80 vs. ZVRA: $9.41)
Brand notoriety: CRNX and ZVRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRNX: 61% vs. ZVRA: 1%
Market capitalization -- CRNX: $2.79B vs. ZVRA: $532.58M
CRNX [@Biotechnology] is valued at $2.79B. ZVRA’s [@Biotechnology] market capitalization is $532.58M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRNX’s FA Score shows that 0 FA rating(s) are green whileZVRA’s FA Score has 1 green FA rating(s).

  • CRNX’s FA Score: 0 green, 5 red.
  • ZVRA’s FA Score: 1 green, 4 red.
According to our system of comparison, ZVRA is a better buy in the long-term than CRNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRNX’s TA Score shows that 4 TA indicator(s) are bullish while ZVRA’s TA Score has 5 bullish TA indicator(s).

  • CRNX’s TA Score: 4 bullish, 6 bearish.
  • ZVRA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ZVRA is a better buy in the short-term than CRNX.

Price Growth

CRNX (@Biotechnology) experienced а -0.63% price change this week, while ZVRA (@Biotechnology) price change was +1.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

CRNX is expected to report earnings on Aug 08, 2025.

ZVRA is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($2.79B) has a higher market cap than ZVRA($533M). ZVRA YTD gains are higher at: 12.830 vs. CRNX (-41.717). ZVRA has higher annual earnings (EBITDA): -60.3M vs. CRNX (-373.49M). CRNX has more cash in the bank: 1.27B vs. ZVRA (62.6M). CRNX has less debt than ZVRA: CRNX (50.8M) vs ZVRA (61.8M). ZVRA has higher revenues than CRNX: ZVRA (40.6M) vs CRNX (760K).
CRNXZVRACRNX / ZVRA
Capitalization2.79B533M524%
EBITDA-373.49M-60.3M619%
Gain YTD-41.71712.830-325%
P/E RatioN/AN/A-
Revenue760K40.6M2%
Total Cash1.27B62.6M2,035%
Total Debt50.8M61.8M82%
FUNDAMENTALS RATINGS
CRNX vs ZVRA: Fundamental Ratings
CRNX
ZVRA
OUTLOOK RATING
1..100
5074
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
84
Overvalued
PROFIT vs RISK RATING
1..100
6865
SMR RATING
1..100
9499
PRICE GROWTH RATING
1..100
6438
P/E GROWTH RATING
1..100
10026
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ZVRA's Valuation (84) in the null industry is in the same range as CRNX (91) in the Pharmaceuticals Major industry. This means that ZVRA’s stock grew similarly to CRNX’s over the last 12 months.

ZVRA's Profit vs Risk Rating (65) in the null industry is in the same range as CRNX (68) in the Pharmaceuticals Major industry. This means that ZVRA’s stock grew similarly to CRNX’s over the last 12 months.

CRNX's SMR Rating (94) in the Pharmaceuticals Major industry is in the same range as ZVRA (99) in the null industry. This means that CRNX’s stock grew similarly to ZVRA’s over the last 12 months.

ZVRA's Price Growth Rating (38) in the null industry is in the same range as CRNX (64) in the Pharmaceuticals Major industry. This means that ZVRA’s stock grew similarly to CRNX’s over the last 12 months.

ZVRA's P/E Growth Rating (26) in the null industry is significantly better than the same rating for CRNX (100) in the Pharmaceuticals Major industry. This means that ZVRA’s stock grew significantly faster than CRNX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRNXZVRA
RSI
ODDS (%)
Bullish Trend 5 days ago
75%
Bearish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
85%
Bullish Trend 5 days ago
85%
Momentum
ODDS (%)
Bearish Trend 5 days ago
80%
Bullish Trend 5 days ago
78%
MACD
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 5 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
77%
Bullish Trend 5 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
76%
Bullish Trend 5 days ago
78%
Advances
ODDS (%)
Bullish Trend 5 days ago
77%
Bullish Trend 5 days ago
81%
Declines
ODDS (%)
Bearish Trend 8 days ago
79%
Bearish Trend 8 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 18 days ago
86%
Bearish Trend 5 days ago
79%
Aroon
ODDS (%)
Bearish Trend 5 days ago
84%
Bullish Trend 5 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
QLSCX27.350.30
+1.11%
Federated Hermes MDT Small Cap Core R6
JGMRX23.700.22
+0.94%
Janus Henderson Triton R
CCERX28.040.24
+0.86%
Columbia Large Cap Enhanced Core R
SRORX13.370.11
+0.83%
Calamos Antetokounmpo Sustainable Eqs R6
AFCWX18.00-0.05
-0.28%
American Century Focused Intl Gr R

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with XNCR. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
+1.22%
XNCR - CRNX
59%
Loosely correlated
+1.45%
TRDA - CRNX
57%
Loosely correlated
N/A
IDYA - CRNX
56%
Loosely correlated
+0.82%
DYN - CRNX
56%
Loosely correlated
-2.01%
RVMD - CRNX
55%
Loosely correlated
+1.83%
More

ZVRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZVRA has been loosely correlated with CRNX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ZVRA jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZVRA
1D Price
Change %
ZVRA100%
N/A
CRNX - ZVRA
40%
Loosely correlated
+1.22%
ATXS - ZVRA
39%
Loosely correlated
+1.40%
QURE - ZVRA
38%
Loosely correlated
+0.98%
DNTH - ZVRA
37%
Loosely correlated
+2.56%
ERAS - ZVRA
36%
Loosely correlated
-0.69%
More